SCOPUS 정보 검색 플랫폼

Expert Opinion on Pharmacotherapy

Volumn 2, Issue 2, 2001, Pages 205-211

A pharmacoeconomic appraisal of therapies for hepatitis B and C

(3) Shermock, K M a Temple, M E a Younossi, Z M a

a LERNER RESEARCH INSTITUTE (United States)

Author keywords

Cost effectiveness; Hepatitis B; Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; LAMIVUDINE; RIBAVIRIN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; DRUG EFFICACY; GENOTYPE; HEALTH CARE PLANNING; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; OUTCOMES RESEARCH; QUALITY ADJUSTED LIFE YEAR; RELAPSE; REVIEW;

ANTIVIRAL AGENTS; COSTS AND COST ANALYSIS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; RIBAVIRIN;

EID: 0035001994 PISSN: 14656566 EISSN: None Source Type: Journal
DOI: 10.1517/14656566.2.2.205 Document Type: Review

Times cited : (3)

References (39)

1
- 0024509701
- Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome
- (1989) Science , vol.244 , pp. 359-362
- Choo, Q.L.¹ Kuo, G.² Weiner, A.J.³ Overby, L.R.⁴ Bradley, D.W.⁵ Houghton, M.⁶

2
- 0032583933
- Hepatitis
- (1998) Lancet , vol.351 , pp. 351-355
- Dibisceglie, A.M.¹

3
- 0030006391
- Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis
- (1996) Gastroenterology , vol.111 , pp. 199-205
- Silini, E.¹ Botelli, R.² Asti, M.³

4
- 0004929217
- Chronic hepatitis C: A clinical overview
- (1997) Clev. Clin. J. Med. , vol.341 , pp. 556-562
- Younossi, Z.M.¹

5
- 0027068086
- The natural history of community acquired HCV in the United States
- (1992) N. Engl. J. Med. , vol.327 , pp. 1899-1905
- Alter, M.J.¹ Margolis, H.S.² Krawczynski, K.³

6
- 0033584440
- The prevalence of hepatitis C virus infection in the United States. 1988-1994
- (1999) N. Engl. J. Med. , vol.341 , pp. 556-562
- Alter, M.J.¹ Kruszon-Moran, D.² Nainan, O.V.³

7
- 0030886964
- National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C
- National Institutes of Health
- (1997) Hepatology , vol.26

8
- 0000707195
- Projecting the future health care burden from hepatitis C in the United States
- (1998) Hepatology , vol.28
- Davis, G.L.¹ Albright, J.E.² Cook, S.³ Rosenburg, D.⁴

9
- 0034060956
- Hepatitis C: An update on the silent epidemic
- (2000) J. Clin. Gastroenterol. , vol.30 , pp. 125-143
- Sarbah, S.A.¹ Younossi, Z.M.²

10
- 0027399910
- Natural course of chronic hepatitis
- (1993) C. Am. J. Gastroenterol. , vol.88 , pp. 240-243
- Takahashi, M.¹ Yamada, G.² Miyamoto, R.³ Doi, T.⁴ Ewndo, H.⁵ Tsuiji, T.⁶

11
- 0030800166
- Epidemiological factors affecting the severity of hepatitis C virus related liver disease: A French survey of 6664 patients
- (1997) Hepatology , vol.26 , pp. 485-490
- Roudout-Thoraval, F.¹ Bastie, A.² Palotsky, J.M.³ Dhumeax, D.⁴

12
- 0028952532
- Histopathology of hepatitis C virus infection
- (1995) Semin. Liver Dis. , vol.15 , pp. 70-81
- Goodman, C.D.¹ Ishak, K.G.²

13
- 0345695221
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, control trial
- (1997) Hepatology , vol.26 , pp. 747-754
- Myron, M.J.¹ Reddy, R.² Lee, W.M.³

14
- 0032547938
- Interferon alpha2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- (1998) N. Engl. J. Med. , vol.339 , pp. 1485-1492
- McHutchinson, J.G.¹ Gordon, S.C.² Schiff, E.R.³

15
- 0028903955
- Combined treatment with interferon 2 alpha and ribavirin for chronic hepatitis C patients with a previous non-response or non-sustained response to interferon
- (1995) J. Med. Virol. , vol.46 , pp. 43-47
- Schvarcz, R.¹ Yun, Z.B.² Sonnerborg, A.³ Weiland, O.⁴

16
- 0027367336
- Molecular virology and pathogenesis of hepatitis B
- (1993) Lancet , vol.342 , pp. 1335-1340
- Lau, J.Y.N.¹ Wright, T.L.²

17
- 0019949367
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate
- (1982) Cell , vol.29 , pp. 403-408
- Summers, J.¹ Mason, W.S.²

18
- 0029111949
- From the Centers for disease control and prevention. Update: Recommendations to prevent hepatitis B virus transmission US
- Anonymous
- (1995) JAMA , vol.274 , pp. 603-604

19
- 0025703553
- Protection against viral hepatitis: Recommendations of the immunization advisory committee
- Centers for Disease Control and Prevention
- (1990) MMWR , vol.39 , pp. 1-26

20
- 0028016286
- The epidemiology of viral hepatitis in the United States
- (1994) Gastroenterol. Clin. North Am. , vol.23 , pp. 437-455
- Alter, M.J.¹ Mast, E.E.²

21
- 0023762809
- The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
- (1988) Hepatology , vol.8 , pp. 493-496
- Liaw, Y.F.¹ Tai, D.I.² Chu, C.M.³ Chen, T.J.⁴

22
- 0022523381
- Evolving concepts of the clinical and serological consequences of hepatitis B virus infection
- (1986) Semin. Liver Dis. , vol.6 , pp. 11-22
- Seef, L.B.¹ Koff, R.²

23
- 0028311492
- Therapy of acute and chronic viral hepatitis
- (1994) Adv. Intern. Med. , vol.39 , pp. 241-275
- Hoofnagle, J.H.¹

24
- 1842291578
- The treatment of chronic viral hepatitis
- (1997) Drug Therapy , vol.336 , pp. 347-356
- Hoofnagle, J.H.¹ Di Bisceglie, A.M.²

25
- 0001899571
- Introduction to pharmacoeconomics
- Principles of Pharmacoeconomics (Edition 2). Bootman JL, Townsend RJ, McGhan WF, (Eds.), Harvey Whitney Books, Cincinnati, OH, USA
- (1996) , pp. 4-20
- Bootman, J.L.¹ Townsend, R.J.² McGhan, W.F.³

26
- 0002485840
- Framing and designing the cost-effectiveness analysis
- Cost-effectiveness in Health and Medicine. Gold MR, Siegel JA, Russell LB et al. (Eds.), Oxford University Press, New York, NY, USA
- (1996) , pp. 54-80
- Torrance, G.W.¹ Siegel, J.E.² Luce, B.R.³

27
- 0002013325
- Time Preference
- Cost-effectiveness in Health and Medicine. Gold MR, Siegel JA, Russell LB et al. (Eds.), Oxford University Press, New York, NY, USA
- (1996) , pp. 214-246
- Lipscomb, J.¹ Weinstein, M.C.² Torrance, G.W.³

28
- 0017347943
- Foundations of cost-effectiveness analysis for health and medical practices
- (1977) N. Engl. J. Med. , vol.296 , pp. 716-721
- Weinstein, M.C.¹ Stason, W.B.²

29
- 0032731788
- Cost effectiveness of interferon α2b combined with ribavirin for the treatment of chronic hepatitis C
- (1999) Hepatology , vol.130 , pp. 1318-1324
- Younossi, Z.M.¹ Singer, M.E.² McHutchinson, J.G.³ Shermock, K.M.⁴

30
- 0003726606
- Clinical Decision Analysis
- W.B. Saunders Company, Philadelphia
- (1980)
- Weinstein, M.C.¹ Fineberg, H.V.²

31
- 0028918747
- Cost-effectiveness of interferon-α2b treatment for hepatitis B e antigen-positive chronic hepatitis B
- (1995) Ann. Intern. Med. , vol.122 , pp. 664-675
- Wong, J.B.¹ Koff, R.S.² Tine, F.³ Pauker, S.G.⁴

32
- 0028823771
- Treatment of chronic type B and C hepatitis with interferon-α: An economic appraisal
- (1995) Hepatology , vol.22 , pp. 1863-1873
- Dusheiko, G.M.¹ Roberts, J.A.²

33
- 0028047786
- The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C
- (1994) Med. J. Aust. , vol.160 , pp. 268-272
- Shiell, A.¹ Briggs, A.² Farrell, G.C.³

34
- 0030720484
- Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic hepatitis C
- (1997) Ann. Intern. Med. , vol.127 , pp. 855-865
- Bennett, W.G.¹ Inouey, Y.² Beck, R.³ Wong, J.B.⁴ Pauker, S.G.⁵ Davis, G.L.⁶

35
- 0030671562
- Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis
- (1997) Ann. Intern. Med. , vol.127 , pp. 866-874
- Kim, W.R.¹ Poterucha, J.J.² Hermans, J.E.³

36
- 0034177475
- Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
- (2000) Am. J. Med. , vol.108 , pp. 366-373
- Wong, J.B.¹ Davis, G.L.² Pauker, S.G.³

37
- 0034124763
- Cost-effectiveness of 24 or 48 weeks of interferon-α-2b alone or with ribavirin as initial treatment of chronic hepatitis C
- (2000) Am. J. Gastroenterology , vol.95 , pp. 1524-1530
- Wong, J.B.¹ Poynard, T.² Ling, M.³ Albrecht, J.K.⁴ Pauker, S.G.⁵

38
- 0032547944
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
- (1998) N. Engl. J. Med. , vol.339 , pp. 1493-1499
- Davis, G.L.¹ Esteban-Mur, R.² Rustgi, V.³

39
- 0032583497
- Pre-treatment evaluation of chronic hepatitis C: Risks, benefits and costs
- (1998) JAMA , vol.280 , pp. 2088-2093
- Wong, J.B.¹ Bennet, W.G.² Ko, R.S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.